CYTOKINETICS INC Earnings Per Share Diluted

• CYTOKINETICS INC showed a decrease of -24.3% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2009 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2015: $0.23 (loss) per share | Q1 2016: $0.31 (loss) per share | Q2 2016: $0.29 (loss) per share | Q3 2016: $0.77 per share | Q4 2016: $0.16 per share | Q3 2017: $0.60 (loss) per share | Q2 2021: $0.86 (loss) per share | Q3 2021: $0.95 (loss) per share | Q1 2022: $1.05 (loss) per share | Q2 2022: $0.23 (loss) per share | Q3 2022: $1.52 (loss) per share | Q1 2023: $1.38 (loss) per share | Q2 2023: $1.34 (loss) per share | Q3 2023: $1.35 (loss) per share | Q1 2024: $1.33 (loss) per share | Q2 2024: $1.31 (loss) per share | Q3 2024: $1.36 (loss) per share | Q1 2025: $1.36 (loss) per share | Q2 2025: $1.12 (loss) per share | Q3 2025: $2.55 (loss) per share.
• Over the full 13 years of available data (2009 to 2025), CYTOKINETICS INC's Earnings Per Share Diluted has declined by 1,657.1%.
• Historical annual values: Fiscal year 2025: $6.54 (loss) per share | Fiscal year 2024: $5.26 (loss) per share | Fiscal year 2023: $5.45 (loss) per share | Fiscal year 2022: $4.33 (loss) per share | Fiscal year 2021: $2.80 (loss) per share | Fiscal year 2020: $1.97 (loss) per share | Fiscal year 2017: $2.59 (loss) per share | Fiscal year 2016: $0.39 per share | Fiscal year 2015: $0.97 (loss) per share | Fiscal year 2014: $0.41 (loss) per share | Fiscal year 2011: $0.72 (loss) per share | Fiscal year 2010: $0.77 (loss) per share | Fiscal year 2009: $0.42 per share.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026